Immunome is a clinical-stage targeted oncology company focused on developing targeted therapies to improve outcomes for cancer patients. The company has an innovative portfolio of therapeutics, including antibody-drug conjugates and treatments for desmoid tumors.

Immunome, Inc.

Immunome

Immunome, Inc. | 6,762 followers on LinkedIn. Developing antibody-based therapeutics by unlocking the human memory B cell response. | Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens.

Michael Lefenfeld

Consultant - Pharmaceutical Development Operations

Robert Morgan

Global Quality Management Leader; Quality Compliance & Management Systems| Quality Assurance | Regulatory Expert | Manufacturing Operations

Yomara Gomez-Naiden

Principal Recruiter, Immunome

Erika Herbst

Exciting employment opportunities await you at Immunome! #hiring

COM:IMMUNOME

Immunome

name

homepage url

country

linkedin url

crunchbase url

sector

industry

Description

peer of

competitor of

Metrics